Pilot Study Uses CRP, Calprotectin to Diagnose Pulmonary Exacerbations

Pilot Study Uses CRP, Calprotectin to Diagnose Pulmonary Exacerbations

285695

Pilot Study Uses CRP, Calprotectin to Diagnose Pulmonary Exacerbations

Blood C-reactive protein (CRP) and calprotectin levels can reliably identify pulmonary exacerbations in cystic fibrosis (CF) patients, making them promising diagnostic biomarkers, a pilot study has found. Although further investigations are necessary to determine their clinical applicability, the researchers note that “a step-wise algorithm that incorporates both absolute and fold-change cut-offs can increase the diagnostic performance of these biomarkers.” The study, “Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations,” was published in the Journal…

You must be logged in to read/download the full post.